Those in the control group regained about double that amount
Kobayashi S, Iwamoto M, Kon K, Waki H, Ando S, Tanaka Y
Retatrutide Side Effects Are Similar to Existing Diabetes and Obesity Injectables The most common side effects for retatrutide were: Nausea (16 to 27 percent of participants, depending on dosage, compared with 3.7 percent of those taking a placebo) Diarrhea (19 to 23 percent, compared with 5 percent taking a placebo) Vomiting (16 to 18 percent, compared with 2 percent taking a placebo) Nerve issues (2 to 4 percent, compared with none taking a placebo) Between 2 and 5 percent of participants on retatrutide stopped taking it before the trial ended, with a greater risk of stopping among those who took the highest dose
Get over it and keep going
Depending on the form you take, it may take up to 20 weeks to titrate up to your final maintenance dosage
My Experience with Cost Plus and How It Changed My Life When I entered the freelance world, I was paying out the wazoo for marketplace health insurance